繁體
  • 简体中文
  • 繁體中文

熱門資訊> 正文

Annovis启动600万美元注册直接发行

2025-10-10 20:58

  • Annovis Bio (NYSE:ANVS) has entered into definitive agreements for the purchase of an aggregate of 4M shares of its common stock (or pre-funded warrants in lieu thereof) at a purchase price of $1.50 per share in a registered direct offering, fr gross proceeds of ~$6 million.
  • The closing of the offering is expected to occur on or about October 13, 2025.
  • ANVS -27.27% premarket to $1.6.
  • Source: Press Release

風險及免責提示:以上內容僅代表作者的個人立場和觀點,不代表華盛的任何立場,華盛亦無法證實上述內容的真實性、準確性和原創性。投資者在做出任何投資決定前,應結合自身情況,考慮投資產品的風險。必要時,請諮詢專業投資顧問的意見。華盛不提供任何投資建議,對此亦不做任何承諾和保證。